Upregulation of articular synovial membrane μ-opioid-like receptors in an acute equine synovitis model.

This research investigated how acute inflammation may increase µ-opioid receptors (MOR) in equine synovial membranes, and whether anti-inflammatory treatment could prevent this increase. Results indicate that inflammation does up-regulate MORs, but anti-inflammatory treatment may mitigate this response.

Methodology

• The study used a two-period, blinded, placebo-controlled randomized cross-over design.
• Seven healthy ponies were injected with lipopolysaccharide (LPS, 1.0 ng) into the left or right middle carpal joint. This substance induces localized infection-like symptoms, effectively simulating an inflammatory condition.
• Arthroscopy and synovial membrane biopsies were performed under general anaesthesia at three phases: baseline, 48 hours (T48), and 672 hours (T672) after LPS injection.
• Ponies received either phenylbutazone (PBZ 2.2mg/kg PO BID), which is an anti-inflammatory medication, or a placebo starting from 2 hours post-LPS injection.
• Pain and lameness, indicative of discomfort, were scored to evaluate the effectiveness of the treatment.
• Synovitis, inflammation of the joint lining, was evaluated both macroscopically and microscopically using repeated synovial fluid samples.
• Immunohistochemical techniques were used to determine any changes in the density and staining pattern of MOR-like protein in synovial membrane biopsies over the duration of the inflammation, with or without PBZ treatment.

Key Findings

• The injection of LPS consistently triggered a severe transient synovitis, simulating the effects of acute inflammation.
• Significant pain and lameness were observed following the injection, indicating the effectiveness of the method in inducing inflammation.
• PBZ treatment significantly decreased these symptoms, demonstrating its effectiveness as an anti-inflammatory medication in this context.
• An increase in MOR-like protein was observed in the inflamed equine synovial membrane of the placebo-treated animals. This provides evidence that acute inflammation will up-regulate MOR.
• However, this effect was not observed in the PBZ-treated animals, providing support to the idea that anti-inflammatory treatment could prevent such up-regulation.
• While there were no significant differences at any individual time point between the two groups, the overall observation leads to the conclusion that inflammation can lead to upregulation of MORs, but this can be potentially limited with effective anti-inflammatory treatment.